SurgiQuest Names Jaime Landman, M.D. Chief Medical Director

Apr 29, 2015, 08:03 ET from SurgiQuest, Inc.

MILFORD, Conn., April 29, 2015 /PRNewswire/ -- SurgiQuest, Inc. ("SurgiQuest" or the "Company"), a leading provider of innovative access technologies for minimally invasive surgery (MIS), today announced the appointment of Jaime Landman, M.D. as Chief Medical Director of the Company.

Dr. Landman is currently a Professor of Urology and Radiology and the Chairman of the Department of Urology at the University of California, Irvine School of Medicine, and is a well-respected member of the minimally invasive surgical community. During his professional career, he has authored or contributed to more than 200 peer-reviewed clinical publications, written more than 50 reviews, chapters, and editorials, and received numerous patents from the United States Patent and Trademark Office for surgical devices.

"I am both honored and excited to work with SurgiQuest," said Dr. Landman. "My patients have enjoyed the remarkable benefits of the company's AirSeal® iFS System, and I look forward to working with the SurgiQuest team to expand the use of this unique platform, and to help develop and deliver additional, market changing technology to the surgical community."

Kurt Azarbarzin, SurgiQuest's Founder and Chief Executive Officer, said, "We are absolutely thrilled to have someone of Dr. Landman's prominence join our team at this exciting time in the company's history. His clinical, technical, and strategic contributions in this pivotal role will ensure the continued growth and success of our company."

About SurgiQuest
SurgiQuest, Inc. is a privately held venture-backed company, founded in May 2006. The Company develops, manufactures and markets innovative access technologies for minimally invasive surgery. SurgiQuest's patented AirSeal® iFS System optimizes the laparoscopic environment and provides unparalleled stability in the abdominal cavity during MIS.  Unlike conventional insufflation and trocar systems, the Company's breakthrough integrated platform ensures stable pneumoperitoneum, continuously evacuates smoke and plume when energized medical devices such as electro-cautery, laser or ultrasound are used, and provides valve-free access to the abdominal cavity during both robotic and laparoscopic surgical procedures.  Additional information about SurgiQuest products can be found at www.surgiquest.com.

Investor Contact:
Kurt Azarbarzin
203-799-2400 x200
kazarbarzin@surgiquest.com

Logo- http://photos.prnewswire.com/prnh/20140113/NY44266LOGO

SOURCE SurgiQuest, Inc.



RELATED LINKS

http://www.surgiquest.com